Overview

HU007 Eye Drops in Patients With Dry Eye Syndrome

Status:
Completed

Trial end date:
2019-12-05

Target enrollment:

Participant gender:

Summary

This study is a multicenter, randomized, double blind, Restasis-controlled non-inferiority, Phase III Study to evaluate the efficacy and safety of HU007 eye drops in patients With dry eye syndrome

Phase:

Phase 3

Details

Lead Sponsor:

Huons Co., Ltd.

Treatments:

Ophthalmic Solutions